Documentos relacionados

1. [Fecal lactoferrin in identifying and management of inflammatory bowel disease].
2. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.
3. Histologic scoring indices for evaluation of disease activity in ulcerative colitis.
4. Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease.
5. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.
6. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
7. Evaluation of point-of-care test calprotectin and lactoferrin for inflammatory bowel disease among children with chronic gastrointestinal symptoms.
8. Review of fecal biomarkers in inflammatory bowel disease.
9. Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.
10. The search for gastrointestinal inflammation in autism: a systematic review and meta-analysis of non-invasive gastrointestinal markers.